Showcase Your Work
This is an informal session to help you connect with your peers in a relaxed atmosphere to continue forging new and beneficial relationships.
With an audience of 120+ biopharma and academic experts eager to hear the latest data on next-generation of novel and combination obesity drug development approaches alongside the future of age-related treatment and maintenance regimens. You will have the opportunity to display a poster presenting your own obesity therapeutics research.
Don’t miss out on the chance to connect, learn, and present:
- Position your research at the forefront of the "second wave" of obesity innovation, establishing your team as a key contributor to the evolving science of sustainable weight management and functional health
- Showcase your breakthroughs in triple-agonists, oral small molecules, or muscle-preserving modalities to an audience actively seeking to differentiate their pipelines beyond traditional monotherapies
- Benefit from direct, face-to-face conversation and feedback on your obesity treatments from preclinical and clinical leads at the world's top biopharma organizations to further your research
- Attract strategic interest from stakeholders defining the 2026 pipeline who are specifically looking for the next best-in-class assets and platforms to dominate the future obesity and weight loss market
How to Submit Your Poster
- You must first register your place to attend the 4th Obesity & Weight Loss Drug Development Summit
- Submit an abstract for review to showcase your poster during the Scientific Poster Session
- You will be notified once your abstract has been accepted along with details of printing and size requirements. We do request an online PDF of the poster 2 weeks prior to the summit
- Scientific Poster Session: X
- Abstract Submission Deadline: X
Explore the Full Event Guide
- Access 16+ hours of data-driven content and deep dive into two full days of scientific programming, featuring high-level case studies on triple-agonists, mitochondrial metabolism, and next-generation oral small molecules to define the 2026 obesity pipeline
- Learn more about 2 focused, practical workshops at the pre-conference day featuring hands-on sessions led by Veru Inc. and Canary Cure
- See the world-class faculty including senior leaders from Novo Nordisk, Eli Lilly, and Merck & Co., SixPeaks Bio, Metsera and Syntis Bio
- Find out how you can forge high-value partnerships with senior leaders during 6+ hours of networking
- Explore 7 core strategic pillars from optimizing multi-targeted portfolios to prioritizing muscle quality and functional longevity
